Evidence map›Paper›PMID 21990577›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2011

Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation.

Mathieu Hatt, Catherine Cheze-le Rest, Angela van Baardwijk, Philippe Lambin, Olivier Pradier, Dimitris Visvikis

Abstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Role of interimEuropean journal of nuclear medicine and molecular imaging · 2017
    Pooled it
  2. Trial
  3. Trial
  4. Radiomics and Back Pain.Global spine journal · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Role of Radiomics in Fibrosis Crohn's Disease: A Review.Diagnostics (Basel, Switzerland) · 2023
    Review
  10. Tumors Are Evolutionary Island-Like Ecosystems.Genome biology and evolution · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Radiogenomics Based on PET Imaging.Nuclear medicine and molecular imaging · 2020
    Review
  18. Review
  19. Article
  20. Combining structural and textural assessments of volumetric FDG-PET uptake in NSCLC.IEEE transactions on radiation and plasma medical sciences · 2019
    Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mathieu HattINSERM, U650 LaTIM, CHRU Morvan, Brest, France.
Catherine Cheze-le Rest
Angela van Baardwijk
Philippe Lambin
Olivier Pradier
Dimitris Visvikis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe objectives of this study were to investigate the relationship between CT- and (18)F-FDG PET-based tumor volumes in non-small cell lung cancer (NSCLC) and the impact of tumor size and uptake heterogeneity on various approaches to delineating uptake on PET images.

methodsTwenty-five NSCLC cancer patients with (18)F-FDG PET/CT were considered. Seventeen underwent surgical resection of their tumor, and the maximum diameter was measured. Two observers manually delineated the tumors on the CT images and the tumor uptake on the corresponding PET images, using a fixed threshold at 50% of the maximum (T(50)), an adaptive threshold methodology, and the fuzzy locally adaptive Bayesian (FLAB) algorithm. Maximum diameters of the delineated volumes were compared with the histopathology reference when available. The volumes of the tumors were compared, and correlations between the anatomic volume and PET uptake heterogeneity and the differences between delineations were investigated.

resultsAll maximum diameters measured on PET and CT images significantly correlated with the histopathology reference (r > 0.89, P < 0.0001). Significant differences were observed among the approaches: CT delineation resulted in large overestimation (+32% ± 37%), whereas all delineations on PET images resulted in underestimation (from -15% ± 17% for T(50) to -4% ± 8% for FLAB) except manual delineation (+8% ± 17%). Overall, CT volumes were significantly larger than PET volumes (55 ± 74 cm(3) for CT vs. from 18 ± 25 to 47 ± 76 cm(3) for PET). A significant correlation was found between anatomic tumor size and heterogeneity (larger lesions were more heterogeneous). Finally, the more heterogeneous the tumor uptake, the larger was the underestimation of PET volumes by threshold-based techniques.

conclusionVolumes based on CT images were larger than those based on PET images. Tumor size and tracer uptake heterogeneity have an impact on threshold-based methods, which should not be used for the delineation of cases of large heterogeneous NSCLC, as these methods tend to largely underestimate the spatial extent of the functional tumor in such cases. For an accurate delineation of PET volumes in NSCLC, advanced image segmentation algorithms able to deal with tracer uptake heterogeneity should be preferred.

Indexed as

Positron-Emission TomographyTomography, X-Ray ComputedTumor BurdenBiological TransportCarcinoma, Non-Small-Cell LungFluorodeoxyglucose F18HumansLung NeoplasmsMultimodal ImagingRadioactive TracersFluorodeoxyglucose F18Radioactive Tracers

Identifiers

PMID21990577
PMCPMC3482198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.